James M. Frates
Chief Financial Officer at Amylyx Pharmaceuticals · 7 reported transactions in 2 companies · latest trade Sep 10, 2026
Their trades
Sold | Sep 10, 2026 | Sep 10, 2026 close $32.09 → Oct 29, 2026 close $28.68. S&P 500 +1.9% over the same days. | ||
Sold | Sep 10, 2026 | Sep 10, 2026 close $32.09 → Oct 29, 2026 close $28.68. S&P 500 +1.9% over the same days. | ||
Sold | Feb 2, 2026 | Feb 2, 2026 close $14.67 → Oct 29, 2026 close $28.68. S&P 500 +11.1% over the same days. | ||
Sold | Jan 6, 2026 | Jan 6, 2026 close $11.38 → Oct 29, 2026 close $28.68. S&P 500 +11.6% over the same days. | ||
Sold | Sep 30, 2025 | Sep 30, 2025 close $13.59 → Oct 29, 2026 close $28.68. S&P 500 +15.9% over the same days. |
$34.6K
Sep 10, 2026 close $32.09 → Oct 29, 2026 close $28.68. S&P 500 +1.9% over the same days.
$315.2K
Sep 10, 2026 close $32.09 → Oct 29, 2026 close $28.68. S&P 500 +1.9% over the same days.
$52.1K
Feb 2, 2026 close $14.67 → Oct 29, 2026 close $28.68. S&P 500 +11.1% over the same days.
$37K
Jan 6, 2026 close $11.38 → Oct 29, 2026 close $28.68. S&P 500 +11.6% over the same days.
$154.7K
Sep 30, 2025 close $13.59 → Oct 29, 2026 close $28.68. S&P 500 +15.9% over the same days.